Long-acting amylin analog studied in metabolic pathway research alongside GLP-1 receptor signaling. GLP-1C is currently mixed-batch: the 5mg strength remains Batch 001 with prior verified documentation, and the 10mg strength is Batch 002 with third-party analytical testing in progress. For research use only - not for human consumption.